Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Imidazole → cis-4-((t-Butyldimethylsilyl)oxy)cyclohexan-1-ol
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Imidazole | HCID 795 | — |
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | 1,4-Cyclohexanediol | HCID 11162 | — |
| 반응물 | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | cis-4-((t-Butyldimethylsilyl)oxy)cyclohexan-1-ol | HCID 554539 | 42.4% |
반응 단계
To a solution of 1,4-cyclohexanediol (5 g, 43 mmol), imidazole (2.92 g, 43 mmol) and NEt3 (7 mL) in CH2Cl2 (100 mL) cooled in an ice bath was added tert-butyldimethylsilyl chloride (6.47 g, 43 mmol). The mixture was stirred at room temperature overnight. Water was added and the organic phase was separated. The aqueous layer was extracted with EtOAc. The combined organic phase was dried over MgSO4 and concentrated. Chromatography on silica gel eluting with 3:1 EtOAc/hexanes provided the title compound (4.2 g, 42%) as an oil. MS calculated (M+H)+ 231, found 231.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08729063B2 |
| 출처 데이터셋 | uspto-grants-2014_05 |
| ORD ID | ord-641883d1c79e41cca71d57f46bfb14ed |
| 출처 메모 | uspto-grants-2014_05 |